SD44+/CD24? markers of cancer stem cells in patients with breast cancer of different molecular subtypes

SD44+/CD24? markers of cancer stem cells in patients with breast cancer of different molecular subtypes

Saved in:

Bibliographic Details
Date:	2015
Main Authors:	S. V. Chekhun, T. V. Zadvorny, Yu. O. Tymovska, M. F. Anikusko, O. E. Novak, L. Z. Polishchuk
Format:	Article
Language:	English
Published:	2015
Series:	Experimental Oncology
Online Access:	http://jnas.nbuv.gov.ua/article/UJRN-0000409056
Tags:	Add Tag No Tags, Be the first to tag this record!
Journal Title:	Library portal of National Academy of Sciences of Ukraine \| LibNAS

Institution

Library portal of National Academy of Sciences of Ukraine | LibNAS

Similar Items

СD44+/CD24− markers of cancer stem cells in patients with breast cancer of different molecular subtypes
by: Chekhun, S.V., et al.
Published: (2015)

Are CD44⁺/CD24⁻ cells the assumed cancer stem cells in breast cancer?
by: Ryspayeva, D.E., et al.
Published: (2017)

Association of cd44⁺cd24⁻/low with markers of aggressiveness and plasticity of cell lines and tumors of patients with breast cancer
by: Chekhun, V.F., et al.
Published: (2017)

The value of iodide symporter for prognosis of breast cancer of different molecular subtypes
by: Yu. Lukianova, et al.
Published: (2017)

Expression of CD44 with the progression of the tumor process of breast cancer patients with metabolic syndrome
by: S. M. Hrybach, et al.
Published: (2018)

Analysis of the survival of patients with breast cancer depending on age, molecular subtype of tumor and metabolic syndrome
by: Grybach, S.M., et al.
Published: (2018)

Analysis of the survival of patients with breast cancer depending on age, molecular subtype of tumor and metabolic syndrome
by: Grybach, S.M., et al.
Published: (2018)

Predictive and prognostic potential of CD44 and CD24 expression in primary tumour and after chemotherapy in patients with breast cancer
by: Ryspayeva, D.E.
Published: (2018)

Predictive and prognostic potential of CD44 and CD24 expression in primary tumour and after chemotherapy in patients with breast cancer
by: D. E. Ryspayeva
Published: (2018)

Clinicopathological features of nonspecific invasive breast cancer according to its molecular subtypes
by: Zavyalova, M., et al.
Published: (2016)

Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
by: Chekhun, S., et al.
Published: (2013)

Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
by: S. Chekhun, et al.
Published: (2013)

EpCAM expression in breast tumor cells and their relation to clinical and pathological parameters and molecular subtype of cancer
by: L. M. Kovalevska, et al.
Published: (2019)

Expression of ITSN2 and TKS5 in different subtypes of breast cancer tumors
by: Kropyvko, S.V., et al.
Published: (2019)

Stem cell therapy for hereditary breast cancer
by: Rassi, H.
Published: (2009)

Significance of iodine symporter for prognosis of the disease course and efficacy of neoadjuvant chemotherapy in patients with breast cancer of luminal and basal subtypes
by: Chekhun, V.F., et al.
Published: (2017)

Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer
by: Lukianova, N.Yu., et al.
Published: (2023)

Tumor infiltrating lymphocytes and their impact on the effectiveness of the preoperative chemotherapy in various molecular subtypes of locally advanced breast cancer
by: N. O. Verovkina, et al.
Published: (2017)

Expression of markers of intercellular adhesion CD44 and CD24 in cells of endometrial carcinoma with high malignancy potential
by: I. P. Nesina, et al.
Published: (2019)

Research of stem tumor cells subpopulation on models of breast cancer
by: T. S. Herheliuk, et al.
Published: (2022)

The spectrum of blood serum lipids in patients with breast cancer without metabolic syndrome
by: Timovska, Yu., et al.
Published: (2011)

Orally given chemo-endocrine therapy for patients with luminal Her-2/neu negative metastasing breast cancer
by: Yu. O. Tymovska, et al.
Published: (2016)

Epigenetics in breast cancer
by: Atalay, C.
Published: (2013)

Epigenetics in breast cancer
by: C. Atalay
Published: (2013)

Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
by: Yalovenko, T.M., et al.
Published: (2016)

Features of hepcidin expression in patients with breast cancer
by: Yu. Lukianova, et al.
Published: (2015)

Molecular-genetic bases of clinical heterogeneity of breast cancer (literature review)
by: L. A. Nalieskina, et al.
Published: (2017)

Chromosomal Radiosensitivity in Ukrainian breast cancer patients and healthy Individuals
by: Ryabchenko, N.M., et al.
Published: (2012)

Prospects of the use of molecular markers in cancer of ovaries
by: A. A. Mikhanovskij, et al.
Published: (2015)

Breast cancer with diabetes insipidus
by: Dogan, M., et al.
Published: (2008)

The impact of locoregional treatment on survival of patients with primary metastatic breast cancer
by: Liubota, R., et al.
Published: (2017)

Features of architectonics of neoplasms and molecular profile of tumor cells in patients with breast cancer
by: L. A. Nalieskina, et al.
Published: (2018)

Estimation of content of CD44+CD24– cells as additional criterion of efficiency of preventive therapy in experiment at oncopathology
by: N. A. Bondarovich, et al.
Published: (2008)

Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
by: V. F. Chekhun, et al.
Published: (2015)

A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
by: Shepil, O.V., et al.
Published: (2014)

Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
by: Chekhun, V.F., et al.
Published: (2015)

The use of proteomic technologies in breast cancer research
by: Mazur, M.G., et al.
Published: (2016)

Staging, risk assessment and screening of breast cancer
by: Yalcin, B.
Published: (2013)

Immune checkpoint blockade in breast cancer therapy
by: I. A. Gromakova, et al.
Published: (2020)

The features of reproductive function in women with breast cancer
by: S. E. Ragimzade
Published: (2016)